"The specialty pharmaceutical and medical device company will release Phase 2 clinical data for a combination of Melphalan and its Hepatic Delivery System before the end of the month. The treatment is being developed as a novel treatment for cancer of the liver and bile duct."
Comments Section: Barry says: June 24, 2017 at 2:05 pm Steve where did you get this information about the release of phase 2 data by then end of the month ?
News 
Market Data 
Discover 
